| Reducing the development of antibiotic resistance in critical care units. | |
| | |
MedLine Citation:
|
PMID: 22188438 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Bacteria becoming resistant to an increasing number of antibiotic classes are a major problem at hospitals including critical care units worldwide. Awareness of this problem and the need to prevent the development of antibiotic resistance are very important, especially since very few new antibiotics will become available in the near future. This article gives an overview of the mechanisms of antibacterial resistance and actual resistance data worldwide of the most prevalent Gram positive (MRSA, VISA/VRSE and VRE) and Gram negative bacteria (Pseudomonas aeruginosa, Acinetobacter spp., ESBL producing Enterobacteriaceae and Stenotrophomonas maltophilia). Furthermore, strategies to reduce antibiotic resistance are reviewed. Most important is institution of infection control policies including guidelines on surveillance, isolation of colonized patients and contact precautions, hand hygiene, decolonization measures and environmental decontamination. Antimicrobial stewardship, or striking the balance between an optimal antibiotic treatment for a patient and a minimal risk of development of antibiotic resistance, is another important strategy. Finally, optimizing of antibiotic dosage regimens and thus avoiding underdosage is essential to avoid selection of the most resistant subpopulation of bacteria during antibiotic treatment. Intensive care units with knowledge of local epidemiology of resistance, an effective infection control program and antimicrobial stewardship policy tailored to their specific needs, and using optimal antibiotic dosing regimens have both locally decreased the risk of an outbreak with multi-resistant bacteria, and maybe even more important help to reduce the development of antibiotic resistance. |
| | |
Authors:
|
Marjolein P D Deege; David L Paterson |
Related Documents
:
|
18766648 - Mycoplasma species in chicken flocks with different management systems. 8440088 - Characterization of pasteurella from gingival scrapings of dogs and cats. 100098 - Comparison of direct and modified direct complement-fixation and agar-gel precipitin me... 11959438 - Ismmy1, a novel insertion sequence of mycoplasma mycoides subsp. mycoides small colony ... 9336908 - Streptococcus hyovaginalis sp. nov. and streptococcus thoraltensis sp. nov., from the g... 363698 - Changes in macromolecular synthesis and nucleoside triphosphate levels during glycerol-... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-25 |
Journal Detail:
|
Title: Current pharmaceutical biotechnology Volume: - ISSN: 1873-4316 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-12-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100960530 Medline TA: Curr Pharm Biotechnol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
University of Queensland Centre for Clinical Research, Level 8, Building 71/918 Royal Brisbane Hospital, Brisbane Queensland Australia. david.antibiotics@gmail.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Spectroscopic scanning tunneling microscopy studies of single surface-supported free-base corroles.
Next Document: A novel lily-of-the-valley fragrance contrast agent for magnetic resonance and fluorescence imaging ...